Evidence map›Paper›PMID 40127954›Full record

Trial reportBMJ open quality2025

Supportive supervision visits in a large community hypertension programme in Nigeria: implementation methods and outcomes.

Gabriel Lamkur Shedul, Nanna Ripiye, Erica L Jamro, Ikechukwu A Orji, Grace Julcit Shedul, Eugenia N Ugwuneji, Emmanuel Okpetu, Boni M Ale, Samuel Osagie, Abigail S Baldridge and 4 more

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in BMJ open quality, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04158154 (Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04158154 nacompletednot on this map

Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design

TypeinterventionalSponsorWashington University School of MedicineRan2020 to 2023Enrolled21,922ConditionsHypertensionArmsEvidence-based fixed-dose combination protocol based treatment
3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Implementation science aims to improve healthcare by validating effective interventions.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gabriel Lamkur ShedulCardiovascular Research Unit, University of Abuja, Abuja, Nigeria shedulinks@yahoo.com.ORCID http://orcid.org/0000-0003-2295-908X
Nanna RipiyeCardiovascular Research Unit, University of Abuja, Abuja, Nigeria.
Erica L JamroCardiovascular Division and Global Health Center, Washington University in St Louis, St Louis, Missouri, USA.ORCID http://orcid.org/0000-0003-3431-9653
Ikechukwu A OrjiCardiovascular Research Unit, University of Abuja, Abuja, Nigeria.
Grace Julcit ShedulCardiovascular Research Unit, University of Abuja, Abuja, Nigeria.ORCID http://orcid.org/0000-0002-9277-3208
Eugenia N UgwunejiCardiovascular Research Unit, University of Abuja, Abuja, Nigeria.
Emmanuel OkpetuMedical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Boni M AleInternal Medicine, University of Nairobi, Nairobi, Kenya.
Samuel OsagieCardiovascular Research Unit, University of Abuja, Abuja, Nigeria.
Abigail S BaldridgePreventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID http://orcid.org/0000-0002-1573-0554
Namratha R KandulaMedicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Mark D HuffmanWashington University in St Louis, St Louis, Missouri, USA.
Dike OjjiCardiovascular Research Unit, University of Abuja, Abuja, Nigeria.
Lisa HirschhornMedical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID http://orcid.org/0000-0002-4355-7437

Funding

Transforming Hypertension Management in NigeriaR01HL144708 · NHLBI · WASHINGTON UNIVERSITY · PI Mark D Huffman, Dike Bevis Ojji · 2019 to 2026
$4.3M
Institute of Translational Health SciencesTL1TR000422 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$2.1M
Cardiovascular Research Training In Nigeria (CeRTIN)D43TW011976 · FIC · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Lisa Hirschhorn, Mark D Huffman · 2021 to 2026
$1.4M
FIC NIH HHS D43 TW011976NCATS NIH HHS TL1 TR000422NHLBI NIH HHS R01 HL144708
6 · The paper itself

Abstract

backgroundThe Hypertension Treatment in Nigeria (HTN) Programme established a system for hypertension diagnosis and management in 60 public primary healthcare facilities in the Federal Capital Territory of Nigeria through the implementation of HEARTS, a multi-level strategy bundle including team-based care led by community health extension workers (CHEWs). To improve HEARTS implementation, supportive supervision was added as an implementation strategy in April 2020.

methodsA multidisciplinary supportive supervision team and data collection forms were developed and implemented at HTN-supported sites. Data from April 2020 to December 2023 from supportive supervision visits were used to measure supportive supervision implementation outcomes, including reach, fidelity, adoption and feasibility and effectiveness of quality of care, data reporting and facility readiness. Descriptive analyses were performed to summarise outcomes. Jonckheere-Terpstra or Cochran-Armitage trend test was used to measure change over time for medians or proportions, respectively.

resultsThe programme successfully designed and performed quarterly supportive supervision visits. There was high reach (100% sites with visits each year), fidelity (median 100% (IQR 89%-100%) of core components completed), adoption (100% teams provided quarterly visits) and increase in feasibility (planned visits completed) (90.8% to 97.8%, p=0.002). Effectiveness outcomes included an increase in patients with blood pressure (BP) checked in the last 3 days (78.4% to 84.4%, p=0.009), treatment cards without errors (71.5% to 85%. p<0.001), but a slight drop in CHEW fidelity to BP measurement technique (91.5% to 86.5%, p=0.02). Facility readiness increased in adequate staffing (56.7% to 98.3%, p<0.001), but decreased for equipment availability (98.3% to 90.0%, p=0.03). Overall, the proportion of facilities with all readiness components present increased from 0% to 63.3% (p<0.001).

conclusionsWe designed and implemented a supportive supervision strategy with strong implementation outcomes and most effectiveness outcomes including facility readiness to provide quality hypertension care in Nigeria. This approach can be modelled for supporting HEARTS implementation in other settings. TRIAL REGISTRATION NUMBER: The trial was prospectively registered at www. CLINICALTRIALS: gov under NCT04158154 on 8 November 2019; https://clinicaltrials.gov/ct2/show/NCT04158154.

Indexed as

Health Plan ImplementationHypertensionHumansMass ScreeningNigeriaProgram EvaluationCARDIOVASCULAR DISEASEGlobal HealthHealth services research

Identifiers

PMID40127954
PMCPMC11934367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.